子宮内膜アブレーション装置の世界市場-2023年～2030年

市場概要

子宮内膜アブレーション装置の世界市場は、2022年に35億米ドルに達し、2030年には54億米ドルに達する見通しで、有利な成長が予測されています。世界の子宮内膜アブレーション装置市場は、予測期間中（2023-2030年）に5.6％のCAGRを示すと予測されています。

子宮内膜アブレーション装置は、一般に月経出血として知られる月経出血過多または月経出血過多の女性を効果的に治療できる点で重要です。月経痛は、身体的不快感、精神的苦痛、日常生活の中断をもたらし、女性のQOLに悪影響を及ぼす可能性があります。

子宮内膜アブレーションは、子宮を残したい、あるいは大手術の危険を避けたいと考える女性にとって、子宮摘出術に代わる非手術的な選択肢を提供するものです。子宮内膜アブレーション装置によって、患者はより侵襲的な手術を受けることなく問題を治療することができます。

市場力学

子宮内膜がんの有病率の上昇

子宮内膜がんの有病率の上昇は、予測期間中に市場がさらに成長するための重要な促進要因の1つです。例えば、American Community Survey 2022 updated factsheetによると、米国では60万人以上の子宮内膜がんサバイバーがいます。同じ情報源によると、2022年には約65,950人の子宮体がん（子宮体部または子宮体部）が新たに発見されると予測されています。その結果、子宮内膜がんの罹患率の上昇が、子宮内膜切除装置の需要を押し上げると予測されています。

婦人科疾患の有病率の上昇

女性における子宮頸がん、月経痛、異常膣出血、POCD（多嚢胞性卵巣疾患）などの婦人科疾患の有病率の上昇は、市場成長を促進する主な要因です。子宮頸がんは、2022年2月の世界保健機関（WHO）の最新情報によると、世界で女性に4番目に多いがんで、2020年までに604,000人が新たに発症し、342,000人が死亡しています。低・中所得国は、2020年までに世界の新規患者数と死亡者数の90%近くを占める。その結果、婦人科疾患の有病率の増加が予測期間中の市場成長を促進すると予想されます。

子宮内膜アブレーションに関連するリスク

まれではあるが、以下のようなリスクが手術中または手術直後に発生する可能性があります。子宮筋層を超える穿孔（裂傷）や熱傷などの子宮深部の損傷、腸や膀胱の穿孔（裂傷）や熱傷感染などの腹部臓器の損傷、膣や外陰部、皮膚への熱傷出血（出血）、空気やガスの塞栓症（血管内の気泡）が起こる可能性があります。

COVID-19の影響分析

COVID-19が流行している間、ほとんどの慢性治療が任意治療とみなされたため、ウイルス感染の危険を最小限に抑えるために、すべての外来治療は延期または制限されました。2022年9月にSpringer Journalに掲載された論文によると、COVID-19の流行中、子宮内膜症患者の治療回数は、特に最初の封鎖期間中に制限されました。

子宮内膜症外来は37％減少し、子宮内膜症手術は90％減少しました。このように、COVID-19期間中の子宮内膜症診察と手術の減少は、パンデミックの初期段階における市場成長に大きな影響を与えました。

ロシア・ウクライナ紛争の影響分析

ロシアとウクライナの紛争は、この地域での普及率が低く、主要な市場プレーヤーが不在であることから、世界の子宮内膜アブレーション装置市場に与える影響は中程度と推定されます。しかし、子宮内膜アブレーションデバイスの輸出入の影響は、予測期間中、世界の子宮内膜アブレーションデバイス市場の成長にほとんど影響を与えないと予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 子宮内膜がんの有病率の上昇
    • 承認の増加
  • 抑制要因
    • 子宮内膜アブレーションに伴うリスク
  • 機会
    • 子宮内膜アブレーション装置の技術的進歩の増加
  • 影響分析

第5章 産業分析

• ポーターの5フォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 COVID-19分析

第7章 デバイスタイプ別

• 水熱アブレーター
• 熱バルーンアブレーター
• 子宮鏡装置
• 凍結融解装置
• 高周波子宮内膜アブレーション装置
• マイクロ波子宮内膜アブレーション装置
• その他

第8章 エンドユーザー別

• 病院
• 外来手術センター
• 専門クリニック
• その他

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第11章 企業プロファイル

• Medtronic
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Boston Scientific Corporation
• Cooper Surgical
• Minerva Surgical
• Ethicon
• KARL STORZ GmbH & Co. KG
• Richard Wolf GmbH
• AngioDynamics Inc.
• Smith & Nephew PLC
• Olympus Corporation

第12章 付録

Market Overview

The global endometrial ablation device market reached US$ 3.5 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 5.4 billion by 2030. The global endometrial ablation devices market is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030).

Endometrial ablation devices are significant because they can effectively treat women who have excessive or extended menstrual bleeding, generally known as menorrhagia. Menorrhagia can have a negative influence on a woman's quality of life by producing physical discomfort, mental anguish, and interruption of everyday activities.

Endometrial ablation devices provide a non-surgical option to hysterectomy for women who want to keep their uterus or avoid the hazards of major surgery. It enables patients to treat their problems without having to undergo more intrusive surgery.

Market Dynamics

Rising Prevalence of Endometrial Cancer

The rising prevalence of endometrial cancer is one of the significant key drivers that help the market to grow further during the forecast period. For instance, according to the American Community Survey 2022 updated factsheet, there were over 600,000 endometrial cancer survivors in the United States. According to the same source, around 65,950 new cases of uterine body cancer (uterine body or corpus) are projected to be detected in 2022. As a result, the rising incidence of endometrial cancer is predicted to drive up demand for endometrial ablation devices.

Rise in the Prevalence of Gynaecological Disorders

The rise in the prevalence of gynaecological disorders such as cervical cancer, menorrhagia, abnormal vaginal bleeding, and POCD (polycystic ovarian disease) in women is a major factor driving market growth. Cervical cancer is the fourth most common cancer in women worldwide, according to World Health Organization updates in February 2022, with 604 000 new cases and 342 000 deaths by 2020. Low- and middle-income countries accounted for nearly 90% of new cases and deaths globally by 2020. As a result, the increasing prevalence of gynaecological diseases is expected to drive market growth during the forecast period.

Risks Associated With Endometrial Ablation

While uncommon, the following risks may occur during or shortly after the surgery. Deep uterine damage, such as perforation (tear) or burn beyond the uterine muscle layer, injury to the abdominal organs, such as bowel or bladder perforation (tears) or burns infection, burn harm to the vagina, vulva, and skin haemorrhage (blood loss), embolism of air or gas (air bubble in the blood vessels) can occur.

COVID-19 Impact Analysis

During the COVID-19 epidemic, all outpatient treatments were postponed or limited to minimise the danger of viral transmission, as most chronic therapies were deemed voluntary. According to an article published in the Springer Journal in September 2022, during the COVID-19 pandemic, the number of treatments for endometriosis patients was limited, particularly during the first lockdown.

There was a 37% decrease in the endometriosis outpatient department and a 90% decrease in surgical endometriosis. Thus, the drop in endometrial consultations and surgical operations during COVID-19 had a substantial influence on market growth during the pandemic's early phases.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global endometrial ablation devices market, owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of endometrial ablation devices is expected to have little influence over the global endometrial ablation devices market growth over the forecast period.

Segment Analysis

The global endometrial ablation devices market is segmented based on device type, end user and region.

Hysteroscopy Devices from Device Type Segment Accounts for 23.6% of Market Share

The hysteroscopy devices from the device type segment with around 23.6%. The use of a hysteroscopy instrument offers a real-time picture of the uterine cavity, allowing the clinician to correctly plan and direct the endometrial ablation operation. The hysteroscope aids in visualising the position and extent of the endometrial tissue to be treated, allowing for accurate targeting and total coverage during the ablation procedure. Hysteroscopy instruments allow for continuous monitoring of the treatment progress during the endometrial ablation operation.

For instance, in November 2022, in India, Medtronic introduced a novel instrument for diagnostic and surgical hysteroscopy. India Medtronic, a fully owned subsidiary of Medtronic plc, announced the debut of the TruClear system, a mechanical hysteroscopic tissue removal device used for the safe and effective treatment of intrauterine abnormalities (IUA). Fibroids, polyps, retained products of conception, adhesions, malignancies, or hyperplasia are all examples of IUA.

Geographical Analysis

North America Accounted for Approximately 38.2% of the Market Share

North America is estimated to hold about 38.2% of the total market share throughout the forecast period due to the rising prevalence of gynaecological disorders such as PCOS, abnormal uterine bleeding (AUB), menorrhagia, and escalating cases of cancer such as uterine cancer among women is driving the North American endometrial ablation devices market, which is expected to grow positively.

Competitive Landscape

The major global players in the endometrial ablation devices market include: Medtronic, Boston Scientific Corporation, Cooper Surgical, Minerva Surgical, Ethicon, KARL STORZ GmbH & Co. KG, Richard Wolf GmbH, AngioDynamics Inc., Smith & Nephew PLC, Olympus Corporation and others.

Why Purchase the Report?

• To visualize the global endometrial ablation devices market segmentation based on device type, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the endometrial ablation devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global endometrial ablation devices market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Device Type
• 3.2. Snippet by End User
• 3.3. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising Prevalence of Endometrial Cancer
    • 4.1.1.2. Rise in Approvals
  • 4.1.2. Restraints
    • 4.1.2.1. Risks Associated With Endometrial Ablation
  • 4.1.3. Opportunity
    • 4.1.3.1. Increasing technological advancements in endometrial ablation devices
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's 5 Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post COVID-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Device Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. Hydrothermal ablators *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Thermal balloon ablators
• 7.4. Hysteroscopy devices
• 7.5. Cryoablation devices
• 7.6. Radiofrequency endometrial ablation devices
• 7.7. Microwave endometrial ablators
• 7.8. Others

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospital *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Ambulatory surgical centres
• 8.4. Specialty Clinics
• 8.5. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.5.1. U.S.
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.5.1. Germany
    • 9.3.5.2. U.K.
    • 9.3.5.3. France
    • 9.3.5.4. Spain
    • 9.3.5.5. Italy
    • 9.3.5.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.5.1. Brazil
    • 9.4.5.2. Argentina
    • 9.4.5.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.5.1. China
    • 9.5.5.2. India
    • 9.5.5.3. Japan
    • 9.5.5.4. Australia
    • 9.5.5.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Medtronic*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Boston Scientific Corporation
• 11.3. Cooper Surgical
• 11.4. Minerva Surgical
• 11.5. Ethicon
• 11.6. KARL STORZ GmbH & Co. KG
• 11.7. Richard Wolf GmbH
• 11.8. AngioDynamics Inc.
• 11.9. Smith & Nephew PLC
• 11.10. Olympus Corporation

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us